辅助制剂治疗生物膜性牙龈炎的疗效:系统综述与Meta分析
结果显示,抗菌制剂在3个月和6个月时出血百分比降低均优于对照组,加权均数差分别为10.66%和10.79%(P<0.001)。局部不良反应发生率为0%至13.1%,全身效应评估较少,牙龈炎消退极少被报告和实现。
要点
- 抗菌制剂辅助机械控制可在3个月和6个月时进一步降低牙龈出血百分比。
- 锡氟化物证据为中等质量,氯己定、精油和西吡氯铵证据为低至极低质量。
- 局部不良反应报告率为0%至13.1%,全身效应评估不足。
核心结论
- 在牙龈炎成人中,辅助使用特定抗菌制剂在3个月和6个月时比安慰剂或阴性对照更显著降低牙龈炎症。
- 锡氟化物在3个月时有中等证据支持,氯己定、精油和西吡氯铵为低至极低证据;6个月时氯己定为中等证据,西吡氯铵为低证据,精油为极低证据。
- 不良反应报告不频繁也不全面,牙龈炎消退极少被报告和实现。
研究设计与样本
- 研究对象为系统健康的牙龈炎患者,随访至少3个月,比较活性制剂辅助机械性生物膜控制与阴性对照或安慰剂的疗效。
- 进行了电子检索、研究选择、数据提取、偏倚风险分析、Meta分析和GRADE证据确定性评价。
主要发现
- 抗菌制剂在3个月时出血百分比降低的加权均数差为10.66%(ncomparison=19,P<0.001),6个月时为10.79%(ncomparison=20,P<0.001),均优于对照组。
- 牙龈炎消退极少被判定。
- 局部不良反应(牙相关和软组织相关)发生率范围为0%至13.1%。
- 全身效应评估很少。
- 牙龈炎定义存在高度异质性。
关键数值与推荐
- 局部不良反应发生率范围0%至13.1%。
临床怎么用
- 对于牙龈炎患者,在机械性生物膜控制基础上可考虑辅助使用特定抗菌制剂以进一步减少出血。
- 选择制剂时需参考证据质量:锡氟化物和氯己定证据相对较高,精油和西吡氯铵证据较低。
- 应关注局部不良反应的可能性,并注意全身效应数据有限。
局限性
- 牙龈炎定义存在高度异质性。
- 牙龈炎消退极少被报告和实现。
- 局部不良反应报告不频繁且不全面,全身效应评估很少。
- 证据质量因制剂不同从极低到中等不等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: In systemically healthy humans with gingivitis, what is the efficacy of active agents compared to negative control/placebo when used adjunctively to mechanical biofilm control in terms of changes in gingivitis/bleeding indices and/or disease resolution in randomised controlled clinical trials (RCTs) with at least 3-months follow-up? MATERIAL AND METHODS: Electronic searches, study selection, data extraction, risk of bias analysis, meta-analyses and certainty of the evidence were performed (GRADE). RESULTS: Seventy-two RCTs were included (antiseptics n = 71; systemic intake n = 1). High heterogeneity was found in the definition of gingivitis. Antiseptic agents showed greater reductions in bleeding (%) than control groups at 3 months (ncomparison [nc] = 19; weighted mean differences [WMD] = 10.66%; p < 0.001) and 6 months (nc = 20; WMD = 10.79%; p < 0.001). Gingivitis resolution was rarely determined. Prevalence of local adverse effect (tooth-related and soft-tissue-related) varied from 0% to 13.1%. Systemic effects were scarcely evaluated. CONCLUSIONS: In adults with gingivitis, the adjunctive use of specific antiseptics determined higher reduction of gingival inflammation at 3 months (moderate evidence for stannous fluoride and low-to-very low for chlorhexidine, essential oils or cetylpyridinium chloride [CPC]) and 6 months (moderate for chlorhexidine, low for CPC and very low for essential oils) over placebo/negative controls. Adverse effects are neither frequently nor extensively reported. Gingivitis resolution is rarely reported and achieved.
引用
- Figuero E, Marruganti C, Ambrosio N, et al. Efficacy of Adjunctive Agents in the Management of Biofilm-Induced Gingivitis: A Systematic Review and Meta-Analysis. J Clin Periodontol. 2026. PMID: 42117297. doi:10.1111/jcpe.70121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。